MoneyWorks4Me

Aurobindo Pharma informs about disclosure

12 Sep 2023 Evaluate

With reference to its disclosure made by the Company on July 3, 2023 regarding acquisition of certain marketing and manufacturing related authorisations. Aurobindo Pharma has informed updates regarding the aforesaid disclosure are attached as 'Annexure - I' to this disclosure.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..